Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Induction of TGF-beta by an antiprogestin in the human breast cancer cell line T-47DC Dannecker, K Possinger, S ClassenInternational Journal of Cancer|May 8, 1993
In situ evaluation of the relationship between epidermal-growth-factor-receptor status and tumor-cell proliferation in colon carcinomasR Porschen, S Classen, Y Kahle, et al.Journal of Molecular Biology|December 18, 2001
Crystal structure of the N-terminal domain of Oxytricha nova telomere end-binding protein alpha subunit both uncomplexed and complexed with telomeric ssDNAS Classen, J A Ruggles, S C SchultzCancer Research|January 15, 1994
Vascularization of carcinomas of the esophagus and its correlation with tumor proliferationR Porschen, S Classen, M Piontek, et al.The Journal of Steroid Biochemistry and Molecular Biology|April 1, 1993
Effect of onapristone and medroxyprogesterone acetate on the proliferation and hormone receptor concentration of human breast cancer cellsS Classen, K Possinger, R Pelka-Fleischer, et al.International Journal of Molecular Medicine|September 30, 2009
Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomasR Kopp, M Fichter, G Schalhorn, et al.International Journal of Molecular Medicine|April 11, 2009
Butyrate-induced alterations of phosphoinositide metabolism, protein kinase C activity and reduced CD44 variant expression in HT-29 colon cancer cellsR Kopp, M Fichter, R Assert, et al.Oncogene|June 12, 1997
Expression of CD44 isoforms in neuroblastoma cells is regulated by PI 3-kinase and protein kinase CM Fichter, R Hinrichs, G Eissner, et al.Seminars in Oncology|April 1, 1991
Lonidamine in high-risk breast cancer patientsK Possinger, H Wagner, S Kovacs, et al.Anticancer Research|November 20, 2001
Predictive relevance of soluble CD44v6 serum levels for the responsiveness to second line hormone- or chemotherapy in patients with metastatic breast cancerR Kopp, S Classen, H Wolf, et al.Pageof 2